Article Dans Une Revue Haematologica Année : 2024

Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed / refractory large B-cell lymphoma.

Fichier non déposé

Dates et versions

hal-04872842 , version 1 (08-01-2025)

Identifiants

Citer

L. Falchi, M. Hutchings, C. Carlo-Stella, Franck Morschhauser, M. Dickinson, et al.. Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed / refractory large B-cell lymphoma.. Haematologica, 2024, Haematologica, ⟨10.3324/haematol.2024.286257⟩. ⟨hal-04872842⟩
3 Consultations
0 Téléchargements

Altmetric

Partager

More